Total Payments
$1,097
2022 Payments
$128.67
Companies
8
Transactions
39
Medicare Patients
701
Medicare Billing
$77,114
Payment Breakdown by Category
Food & Beverage$1,071 (97.7%)
Education$25.40 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,071 | 37 | 97.7% |
| Education | $25.40 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $425.18 | 10 | $0 (2020) |
| Gilead Sciences, Inc. | $172.10 | 9 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $171.00 | 4 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $133.22 | 6 | $0 (2019) |
| Janssen Biotech, Inc. | $126.84 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $25.40 | 2 | $0 (2022) |
| Dova Pharmaceuticals | $22.14 | 1 | $0 (2019) |
| QOL Medical, LLC | $20.88 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $128.67 | 6 | Janssen Biotech, Inc. ($103.27) |
| 2020 | $92.87 | 4 | AbbVie Inc. ($37.71) |
| 2019 | $348.90 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($133.22) |
| 2018 | $401.32 | 10 | AbbVie, Inc. ($263.06) |
| 2017 | $125.00 | 1 | Merck Sharp & Dohme Corporation ($125.00) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $36.25 | General |
| Category: Immunology | ||||||
| 04/08/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: Neuroscience | ||||||
| 04/08/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: Neuroscience | ||||||
| 04/06/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunology | ||||||
| 03/29/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Immunology | ||||||
| 03/25/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology | ||||||
| 03/09/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Immunology | ||||||
| 01/31/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: VIROLOGY | ||||||
| 01/17/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.59 | General |
| 11/19/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | APRISO (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Virology | ||||||
| 09/23/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 09/12/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Immunology | ||||||
| 07/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 06/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Immunology | ||||||
| 04/26/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Virology | ||||||
| 02/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 02/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.18 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 68 | 68 | $49,475 | $8,886 |
| 2022 | 9 | 174 | 200 | $149,845 | $20,388 |
| 2021 | 8 | 224 | 253 | $137,940 | $23,836 |
| 2020 | 10 | 235 | 260 | $162,127 | $24,005 |
Total Patients
701
Total Services
781
Medicare Billing
$77,114
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 31 | 31 | $27,020 | $6,057 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $13,294 | $1,666 | 12.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $9,161 | $1,163 | 12.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 17 | 17 | $30,265 | $3,899 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 50 | $15,620 | $3,591 | 23.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 24 | $12,960 | $2,919 | 22.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 40 | $12,000 | $2,678 | 22.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $25,224 | $2,305 | 9.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $30,110 | $2,159 | 7.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $16,946 | $1,281 | 7.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,340 | $873.10 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,380 | $682.54 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 69 | $22,470 | $5,818 | 25.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 31 | $16,740 | $3,938 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 46 | $13,800 | $3,072 | 22.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $25,920 | $2,853 | 11.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $10,540 | $2,482 | 23.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $9,950 | $2,222 | 22.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 17 | 17 | $32,470 | $1,865 | 5.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 28 | $6,050 | $1,586 | 26.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 22 | 22 | $30,380 | $5,225 | 17.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 36 | $19,440 | $4,159 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 38 | $12,140 | $2,527 | 20.8% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 13 | 13 | $18,510 | $2,052 | 11.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $11,580 | $1,985 | 17.1% |
About Dr. Steven Rogers, MD
Dr. Steven Rogers, MD is a Gastroenterology healthcare provider based in Rockport, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548231087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Rogers, MD has received a total of $1,097 in payments from pharmaceutical and medical device companies, with $128.67 received in 2022. These payments were reported across 39 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,071).
As a Medicare-enrolled provider, Rogers has provided services to 701 Medicare beneficiaries, totaling 781 services with total Medicare billing of $77,114. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Rockport, ME
- Active Since 02/01/2006
- Last Updated 10/20/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1548231087
Products in Payments
- Mavyret (Drug) $305.72
- ZEPATIER (Drug) $144.62
- STELARA (Biological) $126.84
- XIFAXAN (Drug) $112.01
- Humira (Biological) $81.75
- ZEPOSIA (Drug) $25.40
- Doptelet (Drug) $22.14
- APRISO (Drug) $21.21
- Sucraid (Drug) $20.88
- MAVYRET (Drug) $19.24
- HUMIRA (Biological) $18.47
- DIFICID (Drug) $15.00
- RENFLEXIS (Biological) $11.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rockport
Jon Stauffer, M.d, M.D
Gastroenterology — Payments: $6,885
Gastroenterology $6,885
Dr. Joseph Minissale, D.o, D.O
Gastroenterology — Payments: $1,721
Gastroenterology $1,721
Eric Elton, Md, MD
Gastroenterology — Payments: $145.44
Gastroenterology $145.44
Kirk Bernadino, Md, MD
Gastroenterology — Payments: $117.33
Gastroenterology $117.33
Neil Smith, Md, MD
Gastroenterology
Gastroenterology